GlucoStabilizer Can Reduce Dosing Errors

In “Deadly Errors Made in Intensive Care”1 of the 38,000 reported mistakes, insulin was the single most common medication associated with errors due to overdosing and underdosing. GlucoStabilizer reduces these risks by:

  • Automatically calculating complex protocols to determine proper IV insulin dosage

  • Replacing multiple protocols and sliding scale efforts with a standardized process of individualized care

  • Eliminating the tendency to not follow a paper insulin dosing protocol

  • Alerting nursing with audible and visual alarms to improve efficiency and timely dosing adjustments

 

Reduce Potential for Errors and Paper Protocol Complexity

  • GlucoStabilizer removes the potential for errors associated with paper protocols through a simple process:

  1. Test Blood Glucose;

  2. Enter Glucose;

  3. Adjust Drip Rate as directed;

  4. IF HYPO, dose D50 as recommended

  • GlucoStabilizer requires nursing confirmation and documents with initials to improve dosing safety.

  • GlucoStabilizer eliminates the variations in how nurses interpret paper protocols and calculate the insulin dose

  • GlucoStabilizer includes a wide range of HIPAA related settings ensure patient confidentiality on all screens

 

 

 

 

  1. John P. Santell, MS, RPh, Rodney W. Hicks, MSN, MPA, Judy McMeekin, From the Center for the Advancement of Patient Safety, U.S. Pharmacopeia, Rockville, Maryland. Journal of Pharmacy Practice, April 1, 2006; 19(2): 124 - 130.

  2. Proceedings from The Seventh Conference, The Cardinal Health Center for Safety and Clinical Excellence. June 7-8, 2007, San Diego, CA, Philip J. Schneider, MS, FASHP, Editor

News  I  Contact Us  I  Home

 © 2011 MAS. All rights reserved.  GlucoStabilizer is a trademark of MAS.